Testing effectiveness (Phase 2)Active Not RecruitingNCT02568566
What this trial is testing
Recombinant Human Papillomavirus Nonavalent Vaccine in Preventing Human Papilloma Virus in Younger Healthy Participants
Who this might be right for
Human Papillomavirus-Related Carcinoma
National Cancer Institute (NCI) 201